The aim of this review was to explore the status of urine sampling as a liquid biopsy for
noninvasive cancer research by reviewing used preanalytical parameters and protocols. We …

Introduction Biological fluids are routine samples for diagnostic testing and monitoring.
Blood samples are typically measured because of their moderate invasive collection and …

Biomarkers are assayed to assess biological and pathological status. Recent advances in
high-throughput proteomic technology provide opportunities for developing next generation …

Body fluid proteome has been intensively studied as a primary source for disease biomarker
discovery. Using advanced proteomics technologies, early research success has resulted in …

Empowered by the advancement of high-throughput bio technologies, recent research on
body-fluid proteomes has led to the discoveries of numerous novel disease biomarkers and …

Purpose To investigate the association between urinary complement proteins and renal
outcome in biopsy-proven diabetic nephropathy (DN). Methods Untargeted proteomic and …

Understanding the tumor heterogeneity through spatially resolved proteome profiling is
important for biomedical research and clinical application. Laser capture microdissection …

Background Reliable high-throughput microbial pathogen identification in human urine
samples is crucial for patients with cystitis symptoms. Currently employed methods are time …

The analysis of serum endogenous peptides holds promise for disease study and drug
discovery, whereas it is relatively unexplored given its challenges in analysis reproducibility …

Renal cell carcinoma is among the top 15 most commonly diagnosed cancers worldwide,
comprising multiple sub-histologies with distinct genomic, proteomic, and clinicopathological …